Galapagos Genomics Ord (OP: GLPGF )

24.55 UNCHANGED

Last Price Updated: 9:30 AM EDT, Jul 18, 2024 Add to My Watchlist

Price and Volume

Volume	0
Open	24.55
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	24.55
Today's Range	24.55 - 24.55
52wk Range	22.60 - 36.21
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Galapagos' Filgotinib Shows Clinical Benefit In Ulcerative Colitis Non-Responding Patients

October 05, 2021

Galapagos NV (NASDAQ: GLPG) announced results of two post-hoc analyses from the SELECTION and SELECTION LTE studies of filgotinib for active ulcerative colitis (UC...

Via Benzinga

Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn's Disease

October 04, 2021

Galapagos NV (NASDAQ: GLPG) has randomized the last patient into the DIVERSITY Phase 3 study of filgotinib in the induction and maintenance of remission in...

Via Benzinga

Performance

YTD	-32.20%	-32.20%
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	+8.63%	+8.63%
1 Year	-27.41%	-27.41%

More News

Galapagos' Long-Serving CEO Onno Van De Stolpe To Exit After R&D Setbacks

August 31, 2021

Via Benzinga

Galapagos' Another Psoriasis Candidate Shows Efficacy, Safety Profile In Mid-Stage Study

July 15, 2021

Via Benzinga

Galapagos Shares Drop As SIK Inhibitor Fails To Show Positive Outcomes In Ulcerative Colitis, Rheumatoid Arthritis Patients

July 15, 2021

Via Benzinga

Galapagos Drops Early Metabolic & Osteoarthritis Programs, Reorganizes R&D Efforts

May 07, 2021

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.